MedTrace Logo

A Prospective Multi-Center Study Using Laser for the Treatment of Melasma and Lentigines in Asian Skin

NCT02385994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-01-31

No results posted yet for this study

Summary

The purpose of this investigation is to evaluate safety and efficacy of the Cutera enlighten dual-pulse duration, dual-wavelength 532nm KTP/1064nm Nd:YAG laser for the treatment of melasma and lentigines on the face in Asian skin.

Conditions

  • Melasma
  • Lentigines

Interventions

DEVICE

enLighten Laser

enLighten Laser treatment with dual-pulse width and dual-wavelength

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Henry Hin-Lee Chan, M.D., Ph.D · Hong Kong Dermatology and Laser Centre

  • Kei Negishi, M.D., Ph.D · Tokyo Women's Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • China
  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02385994 on ClinicalTrials.gov